RavenQuest BioMed Inc. (RVVQF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 30, 2025

RavenQuest BioMed Income Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Jul '19 Oct '18 Oct '17 Oct '16 Oct '15 Oct '14
1.521.260.11---
Revenue Growth (YoY)
0.80%1018.58%----
Cost of Revenue
0.630.460.1---
Gross Profit
0.890.80.01---
Selling, General & Admin
5.414.970.560.070.070.08
Research & Development
0.080.08----
Operating Expenses
14.6813.440.610.070.070.08
Operating Income
-13.79-12.64-0.6-0.07-0.07-0.08
Interest Expense
-3.17-1.9-0.15---
Interest & Investment Income
-----0
Other Non Operating Income (Expenses)
-4.87-4.89-0.05-0.01-0.010.02
EBT Excluding Unusual Items
-21.84-19.43-0.79-0.08-0.08-0.06
Merger & Restructuring Charges
---0.26---
Impairment of Goodwill
-0.01-0.01-2.25---
Asset Writedown
-11.71-11.71----
Other Unusual Items
0.630.11----
Pretax Income
-32.93-31.05-3.3-0.08-0.08-0.06
Income Tax Expense
-0.58-0.58----
Earnings From Continuing Operations
-32.35-30.47-3.3-0.08-0.08-0.06
Minority Interest in Earnings
--0---
Net Income
-32.35-30.47-3.3-0.08-0.08-0.06
Net Income to Common
-32.35-30.47-3.3-0.08-0.08-0.06
Shares Outstanding (Basic)
1149132292929
Shares Outstanding (Diluted)
1149132292929
Shares Change (YoY)
53.47%180.28%12.00%---
EPS (Basic)
-0.28-0.33-0.10-0.00-0.00-0.00
EPS (Diluted)
-0.28-0.33-0.10-0.00-0.00-0.00
Free Cash Flow
-8.11-23.36-2.5-0.03-0.02-0.04
Free Cash Flow Per Share
-0.07-0.26-0.08-0.00-0.00-0.00
Gross Margin
58.63%63.76%13.04%---
Operating Margin
-906.08%-1005.86%-530.18%---
Profit Margin
-2125.41%-2424.36%-2938.14%---
Free Cash Flow Margin
-532.79%-1858.93%-2222.11%---
EBITDA
-9.9-10.76-0.6-0.07-0.070.32
D&A For EBITDA
3.891.880000.4
EBIT
-13.79-12.64-0.6-0.07-0.07-0.08
Advertising Expenses
-0.95----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.